BL Pharmtech Corp.

A065170

KR7065170003

Food Processing

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
493 ^KRW	+1.86%		+7.64%	-2.38%

Mar. 28	Youngchul Park completed the acquisition of 24.43% stake in BL Pharmtech Corp. (KOSDAQ : A065170) from Bioleaders Corporation.	CI
Mar. 20	BL Pharmtech Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Next Bt Co., Ltd. announced that it has received KRW 6.5 billion in funding

January 06, 2020

On January 7, 2020, Next Bt Co., Ltd. (KOSDAQ:A065170) closed the transaction.

Latest news about BL Pharmtech Corp.

Youngchul Park completed the acquisition of 24.43% stake in BL Pharmtech Corp. (KOSDAQ : A065170) from Bioleaders Corporation.	Mar. 27	CI
BL Pharmtech Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
Youngchul Park agreed to acquire 24.43% stake in BL Pharmtech Corp. (KOSDAQ : A065170) from Bioleaders Corporation for KRW 9.3 billion.	Mar. 11	CI
BL Pharmtech agreed to acquire an additional 30.89% stake in Anyone F&C Co., Ltd. for KRW 9 billion	Feb. 14	CI
Kwang Dong Pharmaceutical Co., Ltd. agreed to acquire a 58.73% stake in BL Healthcare Corp. from BL Healthcare Corp. for KRW 30 billion	Dec. 28	CI
BL Pharmtech Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
BL Pharmtech Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
BL Pharmtech Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Next Bt Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-11	CI
Next Bt Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
Next Bt Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-22	CI
Next Bt Co., Ltd. announced that it has received KRW 6 billion in funding from Bioleaders Corporation, Dk Life Science Co., Ltd. and other investors	21-11-30	CI
Next Bt Co., Ltd. announced that it expects to receive KRW 6 billion in funding from Bioleaders Corporation, Dk Life Science Co., Ltd. and other investors	21-11-28	CI
Next Bt Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12	CI
Next Bt Co., Ltd. announced that it has received KRW 10.4 billion in funding from Samsung Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Korea Investment & Securities Co., Ltd., Mirae Asset Venture Investment Co., Ltd., Mirae Asset Securities Co., Ltd.	21-03-30	CI
Next Bt Co., Ltd. announced that it expects to receive KRW 10.4 billion in funding from Samsung Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Korea Investment & Securities Co., Ltd., Mirae Asset Venture Investment Co., Ltd., Mirae Asset Securities Co., Ltd.	21-03-28	CI
Next Bt Co., Ltd. completed the acquisition of the remaining 77.7% stake in TCM Biosciences Inc..	20-07-16	CI
Next Bt Co., Ltd. agreed to acquire the remaining 77.7% stake in TCM Biosciences Inc. for KRW 37 billion.	20-04-19	CI
Next Bt Co., Ltd. acquired 22.25% stake in TCM Biosciences Inc. from Park Young Chul for KRW 15.9 billion.	20-03-30	CI
Next Bt Co., Ltd. announced that it has received KRW 6.5 billion in funding	20-01-06	CI
Next Bt Co., Ltd. announced that it expects to receive KRW 6.5 billion in funding	20-01-02	CI
Next Bt Co., Ltd. announced that it has received KRW 9 billion in funding from KDB Capital Corporation, Investment Arm, IBK Capital Corporation, Meritz Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd.	19-03-26	CI
Next Bt Co., Ltd. announced that it expects to receive KRW 9 billion in funding from KDB Capital Corporation, Investment Arm, IBK Capital Corporation, Meritz Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd.	19-03-24	CI
Next Bt Co., Ltd. acquired 2.76% stake in Bioleaders Corporation for KRW 8 billion.	18-04-23	CI
BioLeaders Corporation acquired additional 21.68% stake in Next Bt Co., Ltd..	18-03-27	CI

BL PharmTech Corp, formerly Next BT Co Ltd, is a Korea-based company primarily engaged in the manufacture and sale of health foods. The Company operates its business through four segments. The Health Functional Food Business segment is engaged in the manufacture and sale of products such as red ginsengs, diet foods and vitamins. The Cosmetics Business segment is engaged in the manufacture and sale of anti-aging skincare products and, among others. The Diagnostic and Medical Business segment is engaged in the manufacture and sale of diagnostic kits and other products. The Other segment is engaged in the distribution of health foods and other products.

Sector

Food Processing

Calendar

2024-05-09 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
BL PHARMTECH CORP.	-2.38%	31.29M
ZHEJIANG NHU COMPANY LTD.	+6.96%	7.69B
BELLRING BRANDS, INC.	+0.34%	7.29B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+5.49%	6.24B
BYHEALTH CO., LTD	-8.63%	3.65B
THE SIMPLY GOOD FOODS COMPANY	-11.31%	3.43B
XIAMEN KINGDOMWAY GROUP COMPANY	-15.49%	1.16B
SIRIO PHARMA CO., LTD.	+10.65%	961M
HERBALIFE LTD.	-42.20%	918M
USANA HEALTH SCIENCES, INC.	-19.99%	841M